Edition:
India

Organovo Holdings Inc (ONVO.OQ)

ONVO.OQ on NASDAQ Stock Exchange Global Market

1.41USD
19 Jan 2018
Change (% chg)

$0.04 (+2.92%)
Prev Close
$1.37
Open
$1.35
Day's High
$1.41
Day's Low
$1.34
Volume
173,667
Avg. Vol
284,035
52-wk High
$3.85
52-wk Low
$1.32

Chart for

About

Organovo Holdings, Inc. is an early commercial-stage company focused on developing and commercializing functional human tissues. The Company focuses on the generation of three-dimensional (3D) human tissues, by utilizing its platform technology to create human tissue constructs in 3D. It is focused on development of products,... (more)

Overall

Beta: 3.21
Market Cap(Mil.): $215.48
Shares Outstanding(Mil.): 105.63
Dividend: --
Yield (%): --

Financials

BRIEF-Organovo Receives Orphan Designation From U.S. FDA For 3D Bioprinted Therapeutic Liver Tissue

* ORGANOVO RECEIVES ORPHAN DESIGNATION FROM U.S. FDA FOR 3D BIOPRINTED THERAPEUTIC LIVER TISSUE TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY Source text for Eikon: Further company coverage:

26 Dec 2017

BRIEF-Organovo posts Q3 loss per share $0.09

* Organovo announces fiscal second-quarter 2018 results; company shifts commercial focus to higher-value disease modeling opportunities and updates full-year fiscal 2018 outlook

10 Nov 2017

BRIEF-Organovo and Viscient Biosciences collaborate to develop custom research platform for studying liver disease

* Organovo and Viscient Biosciences collaborate to develop custom research platform for studying liver disease

06 Nov 2017

BRIEF-Organovo reports Q1 loss per share $0.10

* Organovo announces fiscal first-quarter 2018 results; company affirms full-year fiscal 2018 outlook

10 Aug 2017

Earnings vs. Estimates